Overview
GLOW Blend combines GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg) — three peptides with decades of independent preclinical history and largely non-overlapping signaling routes. Together they cover collagen synthesis, dual-mechanism angiogenesis, cell migration, and matrix remodeling, which makes the blend particularly suited to complex regenerative biology designs that would otherwise require three separate preparations.
Mechanism of Action
Each component engages a distinct arm of the repair cascade: GHK-Cu drives broad transcriptional modulation of collagen synthesis, MMP/TIMP balance, and antioxidant response genes in fibroblast preparations; BPC-157 contributes VEGF-dependent angiogenic signaling through VEGFR2 and FAK phosphorylation; and TB-500 adds VEGF-independent vascular signaling via integrin αvβ3 and Akt-eNOS alongside actin-mediated cell migration. The result is a three-pathway profile addressable from a single pre-formulated vial.
Specifications
- Purity: ≥99% (HPLC) with mass-spectrometry identity confirmation
- Form: Lyophilized powder, pre-blended
- Composition: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg
- CAS Numbers: GHK-Cu: 49557-75-7 · BPC-157: 137525-51-0 · TB-500: 77591-33-4
- Molecular Weights: GHK-Cu: 403.92 Da · BPC-157: 1419.53 Da · TB-500: 4963.44 Da
Research Applications
- Multi-mechanism tissue repair modeling
- Collagen synthesis and ECM remodeling
- Dual-mechanism angiogenesis research
- Cell migration and cytoskeletal studies
- Skin biology and keratinocyte research
- Anti-inflammatory signaling studies





